Vaccine candidate for coronavirus on track for human trials in April
The National Institutes of Health and biotech company Moderna, one of several companies working to develop treatment for the novel coronavirus, are on track for human clinical trials for a vaccine in two and half months, National Institute of Allergy and Infectious Diseases director Anthony Fauci, said in a press briefing Friday.
Why it matters: If the trials prove effective, the vaccine could help protect people from future outbreaks. The researchers were able to successfully take the virus's genetic code and express proteins for animal trials. “I’m happy to tell you there are no glitches so far," Fauci said.